DMBi001-A-1

General

Cell Line

hPSCreg Name
DMBi001-A-1
Cell line type Human induced pluripotent stem cell (hiPSC)
Last update 17th September 2021
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Department of Medical Biotechnology (DMB)

External Databases

BioSamples SAMEA8770928
CLO CLO_0103299
Cellosaurus CVCL_A7LC
Wikidata Q107114814

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
Subclone of

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

External Databases (Donor)

BioSamples SAMEA8770927

Ethics

Also have a look at the ethics information for the parental line DMBi001-A .
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

The source cell information can be found in the parental cell line DMBi001-A.

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Is reprogramming vector detectable?
No
Methods used
PCR

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium Essential 8™

Characterisation

No characterisation data could be found for this subclone. Please open parental cell line DMBi001-A .

Genotyping

Karyotyping (Cell Line)

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
laminin alpha 2-related dystrophy
Synonyms
  • LAMA2-related muscular dystrophy
Genetic modifications
LAMA2 (target)
Gene knock-out
6q22.33
CRISPR-associated (CRISPR/Cas) System